| Home > Facts and
Stats > Selected U.S. National Research Findings >
Group B Strep
Group B
Strep
Selected U.S. National Research Findings
Below are selected national women's health research findings and facts related to
group b strep. This
information is selected text from articles or documents. Please view the source documents below each bulleted section to determine the exact
context.
For more resources on this topic, visit: Group B
Strep: Women's Health Topics A-Z
http://www.cdc.gov/women/az/gbstrep.htm
| •
According to the Active Bacterial Core surveillance system from
1996-2004, the incidence of Group B Strep (GBS) disease in infants aged
0-6 days (i.e., early-onset disease) in 2004 had decreased by 31% from
2000-2001, the period immediately before universal screening was
implemented. •
Incidence of GBS disease in infants aged 7-89 days (i.e., late-onset
disease) remained unchanged during the 9-year period reviewed.
•
Continued monitoring is needed to assess the impact of the 2002
guidelines on early-onset disease and the long-term effect of widespread
intrapartum use of antimicrobial agents on neonatal GBS disease.
Source: Early-Onset and Late-Onset Neonatal Group B
Streptococcal Disease- United States, 1996-2004
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5447a2.htm
|
This site contains documents in PDF format. You will need Adobe Acrobat Reader
to access the file. If you do not have the Acrobat Reader, you may download a
free copy from the
Adobe Web site.
Home | Site Map |
Contact Us
Privacy Policy |
Disclaimer | Accessibility
CDC Home |
Search |
Health Topics A-Z
This page last reviewed
April 10, 2006
URL: http://www.cdc.gov/women/natstat/hlthcare.htm
US
Department of Health and Human Services
Centers for Disease Control and Prevention
Office of Women's Health
|
